Clinical Trial

Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial)

Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to determine whether among symptomatic and asymptomatic carotid artery stenosis (CAS) patients with no known coronary artery disease (CAD) who had undergone carotid artery revascularization (endarterectomy of stenting) a strategy of best medical therapy (BMT) plus selective coronary revascularization based on FFRct assessment of lesion-specific coronary ischemia can reduce adverse cardiac events and improve survival compared to BMT alone. Lesion-specific coronary ischemia is defined as FFRCT ≤0.80 distal to stenosis in a major (≥2 mm) coronary artery with severe ischemia defined as FFRCT ≤0.75.
Trial Details
NCT Number NCT06546761
Lead Sponsor Pauls Stradins Clinical University Hospital
Conditions Carotid Stenosis, Coronary Artery Disease
Enrollment 300 participants
Start Date 2024-06-25
Primary Completion 2027-06-25 (estimated)
Study Completion 2029-06-25 (estimated)
Updated on ClinicalTrials.gov 2024-08-09